Cafepharma Daily Premium (On-Demand) Archive for December, 2018

Click a link below to view the mailing archive as if it had been sent to you.

2018-12-31 12:19		CP Mon Premium
2018-12-29 23:05		CP Sat Premium
2018-12-27 22:25		CP Thu Premium
2018-12-21 23:38		CP Fri Evening Premium: Happy Holidays
2018-12-21 13:34		CP Fri Premium: Top 10 2018 clinical trials with challenges
2018-12-21 00:00		CP Thu Evening Premium: Judge refuses to overturn JNJ verdict
2018-12-20 13:13		CP Thu Premium: Gilead's big end-of-year deals
2018-12-20 00:27		CP Wed Evening Premium: Will 2019 bring a biopharma M&A boom?
2018-12-19 12:40		CP Wed Premium: Pfizer and GSK to combine consumer healthcare units
2018-12-19 00:38		CP Tue Evening Premium: "Bad drug" lawsuit ads
2018-12-18 13:10		CP Tue Premium: Novartis unit strikes medical marijuana deal
2018-12-17 23:36		CP Mon Evening Premium: Pfizer partners with Kineta
2018-12-17 14:17		CP Mon Premium: Clinical data to watch for in 2019
2018-12-17 00:22		CP Sun Premium: Taisho near deal to buy Bristol-Myers OTC unit
2018-12-16 00:52		CP Sat Premium
2018-12-14 14:31		CP Fri Premium: Purdue Pharma's secret Oxy papers
2018-12-13 22:13		CP Thurs Evening Premium: AZ looks for positives in MYSTIC trial
2018-12-13 13:20		CP Thurs Premium: FDA news
2018-12-13 00:07		CP Wed Evening Premium: Akero gets windfall round
2018-12-12 13:02		CP Wed Premium: Eli Lilly buys preclinical Alzheimer's drug
2018-12-12 00:29		CP Tues Evening Premium: Amgen teams with Entera
2018-12-11 13:34		CP Tues Premium: FDA's Gottlieb blasts insulin prices
2018-12-10 23:53		CP Mon Evening Premium: Boehringer laying off 300 in France
2018-12-10 13:16		CP Monday Premium: Gilead taps a new CEO
2018-12-10 00:16		CP Sun Premium
2018-12-08 12:34		CP Sat Premium
2018-12-07 12:36		CP Fri Premium: AstraZeneca's Imfinzi has another trial failure
2018-12-06 23:47		CP Thurs Evening Premium: Moderna's $604M IPO
2018-12-06 13:42		CP Thurs Premium: Another new generic EpiPen alternative
2018-12-06 00:01		CP Wednesday Evening Premium: FDA breaks record for NME approvals
2018-12-05 13:05		CP Wednesday Premium: The most expensive drugs + AI news
2018-12-04 23:56		CP Tuesday Evening Premium: China drug approvals
2018-12-04 13:01		CP Tuesday Premium: The last day of ASH
2018-12-03 23:04		CORRECTION: CP Monday Evening Premium: More ASH news
2018-12-03 23:01		CP Saturday Premium: U.S., Canada, Mexico sign USMCA, committing to 10 years biologics exclusivity
2018-12-03 12:42		CP Monday Premium: GSK buying Tesaro
2018-12-02 23:06		CP Sunday Premium: The latest from ASH 2018
2018-12-01 12:44		CP Saturday Premium: U.S., Canada, Mexico sign USMCA, committing to 10 years biologics exclusivity

<< Archive Index • Subscribe >>

Cafepharma Daily Premium (On-Demand) Archive for December, 2018

Contact Us

Past Issues

Unsubscribe